詳細(xì)信息
- ;TAS-6417;2-丙酰胺,N-[(8S)-4-氨基-8,9-二氫-6-甲基-5-(3-喹啉基)嘧啶[5,4-b]吲哚嗪-8-基]-;(S)-N-[4-氨基-6-甲基-5-(3-喹啉基)-8,9-二氫嘧啶并[5,4-B]吲嗪-8-基]丙烯酰胺;齊帕勒替尼;(S)-N-(4-氨基-6-甲基-5-(喹啉-3-基)-8,9-二氫嘧啶并[5,4-B]中氮茚-8-基)丙烯酰胺;(S)-N-(4-氨基-6-甲基-5-(喹啉-3-基)-8,9-二氫嘧啶并[5,4-B]吲嗪-8-基)丙烯酰胺;
- Zipalertinib (TAS-6417)
- ;TAS-6417;(S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide;2-Propenamide, N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]-;CLN-081;Propenamide, N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]- (ACI);Zipalertinib;
- CAS NO：1661854-97-2
免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。